INJURY | PERSONAL INJURY LAWYER | PERSONAL INJURY ATTORNEY | INJURIES |
SITE MAP |
|
Jan. 3, 2008—The FDA announced that it is reviewing data from anemia drugs that have been linked to rapid tumor growth and shortened survival time in patients with certain types of cancer. The anemia drugs, called erythropoiesis-stimulating agents, or ESAs, affect patients with certain types of cancer, including:
Common ESAs have the market names Aranesp, Epogen and Procrit. For the time begin, there are very few, and in some cases, no alternatives to ESAs for anemic patients. Patients should discuss the risks with their healthcare providers before using ESAs. Patients using ESAs are also at risk for blood clots, strokes, heart failure and heart attacks, especially patients with kidney disease. Mary E. Ramos is an experienced Houston Divorce Lawyer committed to the practice of Texas family law, adoption, child support, child custody and divorce mediation. Family Law Solicitor – LawPlus provides legal service in the areas of Family Law, Employment Law, Home Law and Commercial Law and also commit to providing you with a different experience – a better experience. Looking for a Boston Divorce Lawyer? The law firm of Hans Hailey specializes in Family Law (divorce) and Personal Injury in the Boston Massachusetts area.
Tags: anemia, blood clots, heart attacks, heart failure, strokes Related Posts: 16-Pound Tumor Threatens Girl’s Life Generic Drugs Are Not As Effective, Some Say California to Track Prescription Drugs Do you need legal assistance? If you think you may need the assistance of an attorney please fill out our contact form. |
Categories
ArchivesLinks |
| © 2008 Injury.com
|
Leave a reply